Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis
- 31 May 2002
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 160 (5), 1867-1875
- https://doi.org/10.1016/s0002-9440(10)61133-9
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuriesAmerican Journal of Hematology, 1998
- ANIMAL MODELS OF SEPSIS AND SHOCKShock, 1998
- Inhibition of Tissue Factor and Cytokine ReleasePathophysiology of Haemostasis and Thrombosis, 1996
- Characterization of the Murine Plasma Fibrinolytic SystemJBIC Journal of Biological Inorganic Chemistry, 1994
- Multiple Organ Failure Pathophysiology and Potential Future TherapyAnnals of Surgery, 1992
- C5a-mediated release of interleukin 6 by human monocytesClinical Immunology and Immunopathology, 1990
- The Role of Plasma Proteases in Septic ShockNew England Journal of Medicine, 1989
- C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.The Journal of Experimental Medicine, 1988
- Cultured human endothelial cells generate tissue factor in response to endotoxin.JCI Insight, 1983
- Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.The Journal of Experimental Medicine, 1982